Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$75.08 - $121.99 $343,040 - $557,372
-4,569 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$116.17 - $194.55 $530,780 - $888,898
4,569 New
4,569 $531,000
Q2 2021

Aug 16, 2021

SELL
$130.4 - $225.58 $216,724 - $374,913
-1,662 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$124.11 - $190.17 $206,270 - $316,062
1,662 New
1,662 $220,000
Q2 2020

Aug 13, 2020

SELL
$57.2 - $74.41 $1.64 Million - $2.14 Million
-28,727 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$57.05 - $95.75 $3.28 Million - $5.51 Million
-57,545 Reduced 66.7%
28,727 $1.93 Million
Q4 2019

Feb 14, 2020

SELL
$68.3 - $93.8 $310,013 - $425,758
-4,539 Reduced 5.0%
86,272 $7.27 Million
Q3 2019

Nov 14, 2019

BUY
$61.86 - $97.8 $2.13 Million - $3.36 Million
34,402 Added 60.99%
90,811 $6.79 Million
Q2 2019

Aug 14, 2019

BUY
$42.22 - $63.23 $2.08 Million - $3.11 Million
49,254 Added 688.39%
56,409 $3.57 Million
Q1 2019

May 15, 2019

BUY
$31.96 - $56.12 $228,673 - $401,538
7,155 New
7,155 $345,000
Q2 2018

Aug 14, 2018

SELL
$19.85 - $32.0 $613,841 - $989,568
-30,924 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$19.3 - $23.65 $48,655 - $59,621
-2,521 Reduced 7.54%
30,924 $674,000
Q4 2017

Feb 14, 2018

SELL
$16.3 - $21.9 $54,719 - $73,518
-3,357 Reduced 9.12%
33,445 $676,000
Q3 2017

Nov 14, 2017

BUY
$18.05 - $21.75 $664,276 - $800,443
36,802
36,802 $731,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.86B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.